TG2 is an important predictive and prognostic factor 4,59 and analysis of the gene expression profile of TGM2 can be useful to test potential effects for evaluation of efficacy/resistance to therapy in patients with BrCa, performing predictive in vitro experiments before setting up in vivo administration. Here, TGM2 is linked to invasive breast carcinoma.